Live: Will Casey’s Crush Q4 Earnings Tonight After The Bell?

Investing

Merck : MRK

All Merck Articles

1079 Articles

Jon C. Ogg | Jul 11, 2014 at 7:40 AM EDT

Short Sellers Get Aggressive in Defensive High-Yield Dividend Stocks

The short interest data for the June 30 settlement date is out, and there were selectively an increasing number of…

Jon C. Ogg | Jul 1, 2014 at 7:55 AM EDT

The Five Best Performing DJIA Stocks of 2014

The second quarter of 2014 has come and gone, which means that we are now already half way through 2014.…

Jon C. Ogg | Jun 25, 2014 at 10:05 AM EDT

Short Interest Screams Higher in Defensive High-Yield Stocks

The short interest data for the first two weeks of June show that short interest was higher in almost all…

Jon C. Ogg | Jun 11, 2014 at 11:45 AM EDT

Short Sellers Get Selective in High-Yield Defensive Dividend Stocks

ThinkstockThe short interest data for the final two weeks of May have been released, and the results are somewhat surprising…

Jon C. Ogg | Jun 10, 2014 at 8:20 AM EDT

After Idenix: The Next Four Biotech Buyout Candidates

Here are the four top biotech names we found that all have hepatitis C drugs in their current pipelines at…

Jon C. Ogg | Jun 9, 2014 at 12:45 PM EDT

The Top Seven DJIA Stocks of 2014 Expected to Keep Rising

24/7 Wall St. wanted to look at the leaders and laggards in the Dow Jones Industrial Average. It turns out…

Paul Ausick | May 29, 2014 at 4:01 PM EDT

The 4 Stocks That Dominated the Market

thinkstockMay 29, 2014: Markets opened higher on Thursday following reports that U.S. GDP contracted by 1% in the first quarter…

Jon C. Ogg | May 27, 2014 at 1:35 PM EDT

Pfizer’s Real Issue: Identity Crisis Against Peers

Pfizer looks like it is out of the bid now for AstraZeneca. What looks increasingly obvious for a lackluster performance…

Paul Ausick | May 8, 2014 at 4:01 PM EDT

The 4 Stocks That Mixed Up the Market

thinkstockMay 8, 2014: Markets opened lower on Thursday and posted solid gains on a good report on new claims for…

Jon C. Ogg | May 8, 2014 at 8:30 AM EDT

Top Analyst Upgrades and Downgrades: Chevron, Exxon, Merck, Tesla, Disney, Yelp and More

These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, May 8, 2014. They include Chevron, Exxon,…

Paul Ausick | May 6, 2014 at 4:01 PM EDT

The 4 Stocks That Tanked the Market

thinkstockMay 6, 2014: Markets opened lower on Monday and sank slowly and surely for the rest of the day. The…

Paul Ausick | May 6, 2014 at 11:05 AM EDT

Cross-Border Premium Implications in Merck-Bayer Transaction

Merck has had its consumer products business on the market since the beginning of this year, and Tuesday it announced…

Jon C. Ogg | May 3, 2014 at 8:35 AM EDT

The Four Best DJIA Stocks of 2014 So Far, and Looking Forward

This past week brought yet another swing taking the Dow Jones Industrial Average to within 30 points or so of…

Paul Ausick | May 2, 2014 at 11:20 AM EDT

Can Endocyte Survive Its Cancer Drug Implosion?

Endocyte and Merck have terminated their joint late-stage study of an ovarian cancer treatment after the trials failed to show…

Jon C. Ogg | Apr 30, 2014 at 8:30 AM EDT

Top Analyst Upgrades and Downgrades: Coach, Merck, Netflix, Sprint, Twitter and More

These are the top analyst upgrades, downgrades and initiations from Wall Street on Wednesday, April 30, 2014. They include ARM…

1 … 47 48 49 50 51 … 72

Merck : MRK

All Merck Articles

Short Sellers Get Aggressive in Defensive High-Yield Dividend Stocks

The Five Best Performing DJIA Stocks of 2014

Short Interest Screams Higher in Defensive High-Yield Stocks

Short Sellers Get Selective in High-Yield Defensive Dividend Stocks

After Idenix: The Next Four Biotech Buyout Candidates

The Top Seven DJIA Stocks of 2014 Expected to Keep Rising

The 4 Stocks That Dominated the Market

Pfizer’s Real Issue: Identity Crisis Against Peers

The 4 Stocks That Mixed Up the Market

Top Analyst Upgrades and Downgrades: Chevron, Exxon, Merck, Tesla, Disney, Yelp and More

The 4 Stocks That Tanked the Market

Cross-Border Premium Implications in Merck-Bayer Transaction

The Four Best DJIA Stocks of 2014 So Far, and Looking Forward

Can Endocyte Survive Its Cancer Drug Implosion?

Top Analyst Upgrades and Downgrades: Coach, Merck, Netflix, Sprint, Twitter and More

Live: Will Casey’s Crush Q4 Earnings Tonight After The Bell?

Apple Will Run Advanced AI Model on Nvidia GPUs via Google Cloud, Ditching Private Infrastructure

Will XRP Explode? The Rare RSI Signal That Preceded Every Major Rally Just Flashed Again

The Capex Signal That Will Make or Break IGPT in the Next 12 Months

Fidelity's 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

74-Year-Old With $2.6M Discovers Late Husband's IRA RMD Doubled Her Tax Bill

Apple Will Run Advanced AI Model on Nvidia GPUs via Google Cloud, Ditching Private Infrastructure

Will XRP Explode? The Rare RSI Signal That Preceded Every Major Rally Just Flashed Again

Merck : MRK

All Merck Articles

Short Sellers Get Aggressive in Defensive High-Yield Dividend Stocks

The Five Best Performing DJIA Stocks of 2014

Short Interest Screams Higher in Defensive High-Yield Stocks

Short Sellers Get Selective in High-Yield Defensive Dividend Stocks

After Idenix: The Next Four Biotech Buyout Candidates

The Top Seven DJIA Stocks of 2014 Expected to Keep Rising

The 4 Stocks That Dominated the Market

Pfizer’s Real Issue: Identity Crisis Against Peers

The 4 Stocks That Mixed Up the Market

Top Analyst Upgrades and Downgrades: Chevron, Exxon, Merck, Tesla, Disney, Yelp and More

The 4 Stocks That Tanked the Market

Cross-Border Premium Implications in Merck-Bayer Transaction

The Four Best DJIA Stocks of 2014 So Far, and Looking Forward

Can Endocyte Survive Its Cancer Drug Implosion?

Top Analyst Upgrades and Downgrades: Coach, Merck, Netflix, Sprint, Twitter and More

Live: Will Casey’s Crush Q4 Earnings Tonight After The Bell?

Apple Will Run Advanced AI Model on Nvidia GPUs via Google Cloud, Ditching Private Infrastructure

Will XRP Explode? The Rare RSI Signal That Preceded Every Major Rally Just Flashed Again

The Capex Signal That Will Make or Break IGPT in the Next 12 Months

Featured Reads

Fidelity's 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

74-Year-Old With $2.6M Discovers Late Husband's IRA RMD Doubled Her Tax Bill